ChatGPT SearchAug 23, 2026
If your team already has good biology and medicinal chemistry but lacks computational-design capacity, Iktos is worth looking at.
Loading…
Data as of Oct 20, 2026Based on 723 AI responses
Reviewed by Dimitry Apollonsky
AI summary
Iktos provides a platform for drug discovery that integrates molecule design software with robotic synthesis and testing tools.
3%
across Iktos’s markets · since Jul 5
Question: Which AI-native platforms help small biotech teams compete with large pharma research groups?
ChatGPT SearchAug 23, 2026
If your team already has good biology and medicinal chemistry but lacks computational-design capacity, Iktos is worth looking at.
Each engine’s share of its own answers across Iktos’s markets · since Jul 5
This page is cited in 7% of the answers that name Iktos.
Review this page on your site for accurate product details and clear explanations of who it helps.
All-time evidence through 2026-09-26.
Review the page on iktos.ai (opens in a new tab)iktos.ai 13%Other sites 87%
Question: Which AI-native platforms help small biotech teams compete with large pharma research groups?
Google AI ModeAug 15, 2026
Iktos : Uses generative software (Makya ) for de novo ligand design and retrosynthesis prediction (Spaya )
Question: What's the best AI tool to design small molecules with better predicted potency?
Google AI ModeAug 13, 2026
Iktos Makya (which utilizes generative deep learning tied to synthetic accessibility constraints)
Excerpts where Iktos appeared in the AI's answer
Iktos Makya (which utilizes generative deep learning tied to synthetic accessibility constraints)
Iktos (Makya & Spaya) : Best-in-class for synthesis-aware generative design.
Excerpts where Iktos appeared in the AI's answer
Iktos — Specializes in𝑑𝑒𝑛𝑜𝑣𝑜 generative molecular design paired with automated retrosynthetic analysis .
Excerpts where Iktos appeared in the AI's answer
Iktos: Applies generative models to automate de novo design and retrosynthesis
Iktos: Provides generative models for de novo design, allowing researchers to create molecules that meet specific ADMET and selectivity profiles.
Excerpts where Iktos appeared in the AI's answer
If your team already has good biology and medicinal chemistry but lacks computational-design capacity, Iktos is worth looking at.
Iktos : Uses generative software (Makya ) for de novo ligand design and retrosynthesis prediction (Spaya )
